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Abstract 
 
Background 
Mental health specialist services in low and middle income countries (LMIC) are scarce. The aim of 
this review was to  identify effective interventions and treatment guidelines to manage common types 
of psychiatric emergencies in non-specialist settings in LMIC. 
 
Methods 
We conducted a systematic review of interventions for psychiatric emergencies and a literature search 
for LMIC-specific treatment guidelines for psychiatric emergencies.  
 
 Outcomes 
We identified one randomised controlled trial from LMIC which indicated that a brief psychosocial 
intervention delivered to patients with attempted suicide/s resulted in significant reduction in 
completed suicide/s but not in repeated suicidal behaviour. We identified 22 treatment guidelines for 
psychiatric emergencies in LMIC, but only one was based on context-relevant evidence or developed 
following rigorous procedures.  The guidelines included those on the ‘neuroses’ spectrum, 
externalising spectrum, suicidal behaviour and substance use related presentations. The most 
commonly covered phenotypes were alcohol intoxication (monitoring of vital signs, supportive 
interventions and symptomatic management), alcohol withdrawal (sedation, thiamine, symptomatic 
treatment), and suicidal behaviour (risk assessment, management of risk, referral to relevant 
specialists). None of the guidelines dealt with the issue of people with mental illness who are unable 
to consent to treatment. 
 Interpretation  
There is a dearth of high quality guidelines and contextualised primary evidence for management of 
psychiatric emergencies in LMIC. This needs to be an urgent research priority given the adverse 
health and social consequences of such presentations and the current drive to scale-up mental health 
care.   
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Introduction 
A psychiatric emergency is a severe disturbance of mood, thought, or behaviour that needs an 
immediate intervention.
1
 A large proportion of people attending emergency services in High Income 
Countries (HIC) present with mental health problems requiring treatment. Indeed, in emergency 
services settings, psychiatric emergencies are reported to be as frequent as trauma-related and 
neurological emergencies, constituting up to 12% of emergency service attenders.
2
 Common 
psychiatric disorders found in people presenting to emergency services in HIC include psychoses (12-
29%), substance abuse disorders (6-25%), mood disorders (depression and bipolar disorders) (2-23%) 
and personality disorders (11-20%).
3-5
 Furthermore, in HIC, people with depression, anxiety or 
substance use disorders are high users of emergency medical services.
6
 Many common emergency 
presentations, such as attempted suicide and agitated or disturbed behaviour, cut across diagnostic 
categories.
7,8
 
 
The vast majority of people with mental health problems living in low and middle income countries 
(LMIC) do not have access to treatments that are shown to be efficacious and cost-effective in such 
settings.
9-11
 For this reason, emergency presentations are expected to be more frequent in these 
populations. Due to a variety of factors, including lack of availability of specialist services, people 
with mental health problems often make their first presentation to non-specialist settings.
12,13
 Thus, the 
management of psychiatric emergencies is more likely to fall to non-specialists working in non-
psychiatric settings, for example, primary care or general hospital emergency departments. Health 
professionals working in general health care settings in LMICs therefore need the necessary skills to 
handle psychiatric emergencies. An important resource that would help these health professionals are 
evidence-based guidelines which provide a framework for the management of psychiatric 
emergencies in a non-specialist, LMIC setting. While many such evidence-based guidelines have been 
developed in HIC
14-17
, the generalisability of such guidelines to LMIC may be limited as LMIC may 
differ significantly with regard to characteristics of clinical phenotypes, the available human resources 
for delivering the intervention, available interventions, and mental health legislation with regards to 
involuntary treatment.  
  
The aim of this review was two-fold, 1) To identify and evaluate the evidence base for the 
effectiveness of interventions for psychiatric emergencies in adults in non-specialist settings in LMIC; 
and 2) To review the availability, coverage, and quality of treatment guidelines for psychiatric 
emergencies in LMIC.   
 
Methods 
Systematic review of the literature 
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This systematic review was carried out in line with the PRISMA statement for reporting systematic 
reviews 
18
 and was guided by a review protocol. 
Randomised and non-randomised controlled trials, observational studies, pilot studies, and case series 
were included if they were conducted in any setting except specialist mental health settings e.g. 
general hospitals, emergency departments, primary care and mental health services provided by Non-
Governmental Organisations (NGO) in any LMIC as defined by the World Bank at the time that the 
study was carried out (http://data.worldbank.org/about/country-classifications/country-and-lending-
groups). Interventions delivered in specialist psychiatric settings (e.g. psychiatric wards, psychiatric 
emergency departments) were excluded as the goal of the review was to examine interventions that 
could be delivered in non-specialist settings. Interventions delivered to children and adolescents or 
delivered in post-conflict or humanitarian settings were excluded as they address issues in specific 
patient groups and settings which have distinct requirements which are beyond the scope of this 
review.  
 
The search took the approach of focusing on phenotypic presentations (for example, suicide attempts) 
as they are likely to have more relevance in non-specialist emergency settings. To ensure a 
comprehensive search of priority phenotypes, the search terms were informed by a survey of experts. 
A consensus list of phenotypic presentations was generated based on discussion among the author 
group.  World Psychiatric Association (WPA) regional and country representatives and other key 
informants identified by the authors were contacted by e-mail and invited to respond to the survey 
(Appendix 1). Experts were asked to rate a list of phenotypic presentations (e.g. aggression/violence, 
mute/uncommunicative, self-harm, bizarre behaviour) on a three point Likert scale of ‘extremely 
relevant’, ‘moderately relevant’ and ‘not relevant’ for their context. They were also asked to suggest 
any other phenotypes which were relevant but not on our list. A total of 27 experts from 17 countries 
(Armenia, Bangladesh, Cambodia, Jordan, Kenya, Moldova, Mongolia, Niger, Sudan, Togo, Uganda, 
Ethiopia, Georgia, India, Pakistan, Egypt, and Nigeria) participated in the survey. 
The following presentations were excluded: seizures, acute adverse effects of psychotropic 
medications, and acute behavioural disturbance due to delirium (as the most common aetiologies are 
not attributed to mental health problems). There were no limits to the delivery agent (e.g. general 
physician, nurse, mental health professional), type of intervention (e.g. psychosocial, 
pharmacological, environmental) and control groups (e.g. no treatment, alternative treatment). The 
detailed inclusion and exclusion criteria are presented in Appendix 2.  
 
We searched the following databases with no restriction on date of publication: Medline, EMBASE, 
PsycINFO, CINAHL (Cumulative Index to Nursing and Allied Health Literature), Cochrane library, 
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Web of Knowledge, LILACS (Literatura Latino Americana em Ciências da Saúde) (comprehensive 
index of scientific and technical literature from Latin America and the Caribbean), Indmed (indexes 
peer reviewed medical journals published from India) and ELDIS (Electronic Development and 
Environment Information System). We searched title, abstract and key words under the following 
concepts: Mental disorder (e.g. schizophrenia, depression, mania), phenotype (e.g. aggression, bizarre 
behaviour), presentation (e.g. acute, emergency, crisis), management (e.g. treatment, intervention, 
therapy), type of country (e.g. developing, under developed, low income) and country (e.g. Bhutan, 
Sudan, Vietnam). The detailed search strategy is included in Appendix 3. The literature search was 
conducted by AN in October 2014. Titles and abstracts of all studies were double screened by AN and 
DF/UB to determine eligibility for full text screening.  Disagreement about eligibility for inclusion in 
the review was resolved by discussion with RS and EK. Data were extracted independently by UB 
and CH using a data extraction form designed to achieve study objectives. The extracted data was 
then checked by AN for consistency and any gaps addressed. Data extracted included the following: 
country, study design, phenotype, diagnostic criteria, sampling strategy, sample size, intervention and 
intervention components, intervention agent and comparison group. We assessed the quality of the 
included RCTs using the Cochrane Risk of Bias tool to rate the RCTs on the following dimensions: 
allocation concealment, blinding of participants & personnel, blinding of outcome assessment, 
incomplete outcome data, selective reporting and other bias. The analyses plan was to do a meta-
analyses if there were enough homogenous studies. 
Guideline search 
To retrieve relevant treatment guidelines, we invited key informants (described above) to identify 
guidelines for psychiatric emergencies which were developed or used in their country. In addition, 
RS, AN and EK conducted a search using Google Scholar with the following search terms: 
'emergency psychiatric clinical guidelines' and 'acute psychiatric clinical guidelines’. CR, SP and SF 
conducted a search for relevant guidelines from Latin American countries and not published in 
English. An a priori decision was taken to include the World Health Organisation’s mhGAP 
intervention guide for mental, neurological and substance use disorders 
19
 in the review as an example 
of high quality guidelines developed through a systematic process and designed for LMIC settings. 
20
 
The quality of guidelines was assessed on three dimensions, namely ‘treatment efficacy’, ‘clinical 
utility’, and ‘guideline development process’ using the American Psychological Association ‘Criteria 
for Evaluating Treatment Guidelines’.21 Data from English language guidelines were extracted 
independently by UB and CH while data from non English guidelines were extracted by CR, SP and 
SF. 
Results 
a) Systematic review 
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The database search returned 16687 papers. After excluding duplicates and ineligible papers, we 
carried out full text evaluation of the remaining 23 papers. 21 papers were excluded as they did not 
describe evaluation of an intervention or were not based in a LMIC or were not conducted in non-
specialist emergency settings (Fig 1). We were able to identify two papers, both evaluating the same 
intervention from the same study, the WHO Multisite Intervention Study on Suicidal Behaviours 
(SUPRE-MISS), a multi-country, individual RCT which evaluated a brief educational intervention 
and periodic follow-up contacts (BIC) for suicide attempters in India, Sri Lanka, Islamic Republic of 
Iran, People’s Republic of China, and Brazil.22,23 Consecutive suicide attempters (defined using 
ICD10 criteria) attending the emergency care departments were randomised to either BIC (n = 922) or 
treatment as usual (TAU) (n = 945). BIC was delivered by a person with clinical experience (e.g. 
doctor, nurse, psychologist) and included TAU plus a one-hour individual information session 
followed by nine follow-up contacts (phone calls or visits) over 18 months. The results showed that 
overall, at 18 months, significantly fewer deaths from suicide occurred in the BIC than in the TAU 
group (0.2% vs. 2.2%, p< 0.001).
23
 However, there was no significant difference between the 
proportion of subjects with repeated suicide attempts in the BIC and TAU groups (7.6% vs. 7.5%).
22
 
Inadequate information was provided regarding variables like allocation concealment, blinding of 
personnel and blinding of outcome assessment, thus raising concerns about potential bias.  However, 
there was considered to be a high risk of selection bias because of selective attrition from the 
intervention and comparison arms (Web table 1). 
b) Literature review of guidelines 
Through the grey literature search and key informants we identified twenty-one treatment guidelines 
(excluding the mhGAP-IG).  We found one set of guidelines each from Thai-Burmese border,
24
 
Uganda,
25
 South Africa (SA),
26
 India,
27
 Namibia,
28
 Malawi,
29
 Kiribati,
30
 Ghana,
31
 Kenya,
32
 Zambia, 
33
 
Ethiopia,
34
 Vanuatu,
35
  Afghanistan
36
 and Colombia.
37
 We found the maximum number of guidelines 
from Brazil (n=4), 
38-41 
followed by Peru (n=3).
42-44
 The mhGAP-IG were developed for use across 
LMICs.
19
 Two set of guidelines (including mhGAP) addressed a range of mental disorders,
19,36
 while 
others  were specific, for example on  the management of opiate disorders,
27 
crack disorders
38
 or 
psychotic disorders
42
. One guideline was specific for the aggression and agitation phenotype
39
. The 
remaining guidelines addressed psychiatric emergencies alongside other medical emergencies.
24-26,28-
35,37,40,41,43,44
  
Web table 2 describes the quality criteria used to evaluate the guidelines and specifies which of the 
guidelines clearly fulfilled each of these criteria. A few claimed to be evidence based and/or based on 
WHO recommendations/other guidelines without specifying the approach followed to evaluate the 
literature.
25,26,33-35
 None of the guidelines fulfilled all of the quality criteria but some 
19,27,31,36
 fulfilled 
many as summarised in web table 2.   With a few exceptions
19,27,31,40 
most of the guidelines did not 
7 
 
consider the level of methodological rigor and clinical sophistication of the evidence supporting the 
intervention proposed.  
We organised the phenotypes under four broad groups: the ‘neuroses’ spectrum (e.g. acute anxiety, 
conversion), externalising symptoms (e.g. agitation, aggression), suicidal behaviour and substance use 
related presentations (e.g. opiate intoxication, alcohol withdrawal). Tables 1 to 4 present a summary 
of the recommendations derived from a synthesis of the recommendations from the various 
guidelines.  Recommendations made in two or more guidelines are classified under ‘common 
recommendations’ and the rest are classified as ‘other recommendations’.  
Tables 1-4 here 
For some phenotypes there were more than one set of guidelines recommending a common 
intervention (e.g. diazepam for alcohol withdrawal), while for other phenotypes only one set of 
guidelines recommended a particular intervention (e.g. diazepam for conversion symptoms). The most 
commonly addressed phenotypes were alcohol intoxication/withdrawal and suicidal behaviour. For 
alcohol intoxication, the ‘common recommendations’ were monitoring of vital signs, supportive 
interventions (e.g. lateral positioning, rehydration) and symptomatic management (e.g. management 
of hypoglycaemia). For alcohol withdrawal the  ‘common recommendations’ included sedation using 
diazepam, prophylaxis against Wernicke Korsakoff syndrome using thiamine, multi vitamin 
supplementation, rehydration and symptomatic treatment (e.g. antipsychotics for psychotic symptoms, 
and benzodiazepines or anti-epileptics for withdrawal seizures). Finally, for suicidal behaviour the 
‘common recommendations’ included detailed risk assessment, management of risk (e.g. treat 
underlying mental illness, liaise with support networks) and referral to specialist professionals as 
appropriate. 
The management of other phenotypes were as follows. Clonazepam is recommended for acute 
anxiety. For agitation and aggression, recommendations included interventions that were verbal (e.g. 
de-escalation through firm but friendly communication), mechanical (e.g. physical restraint) and 
pharmacological (e.g. benzodiazepines like diazepam and anti-psychotics like haloperidol). Diazepam 
and clonidine were recommended for opioid withdrawal. For both crack/cocaine intoxication and 
amphetamine intoxication the principles of treatment were the same i.e. benzodiazepine for 
management of agitation, anti-psychotics for management of psychotic symptoms if any and 
monitoring of vital signs.  
Discussion 
The approach taken in this review to the problem of psychiatric emergencies was based on phenotypic 
presentations rather than on syndromal diagnoses. The rationale for this was that the immediate 
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management of psychiatric emergencies, particularly in non-specialist settings, requires treatment of 
the presenting symptoms that are causing distress, and that this is often distinct from the longer term 
management driven by the syndromal diagnosis. We found only one study empirically evaluating a 
treatment of a psychiatric emergency in a non-specialist settings in LMIC
22,23
 which indicated that a 
brief psychosocial intervention delivered to patients with attempted suicide/s resulted in significant 
reduction in completed suicide/s
23
 but not in repeated suicidal behaviour.
22
 In addition, we were able 
to retrieve 22 treatment guidelines for psychiatric emergencies in LMIC,
24-44
 however, only the 
WHO’s mhGAP-IG19 was based on context-relevant evidence or developed following rigorous 
procedures to ensure clinical utility.  
Data from HIC indicate that there is an increasing trend of psychiatric emergencies presenting to 
general hospitals.
45
 There is no evidence to suggest that this would be any different in LMIC, and 
indeed the burden might be higher on such services for a host of reasons. The shortage of specialist 
human resources in LMIC makes it imperative that non-specialist health service providers are 
adequately trained and equipped to deliver evidence based treatment guidelines. Experiences from 
HIC show that the use of short, focussed training programs for general health care professionals 
improves knowledge, diagnostic accuracy and treatment of psychiatric emergencies in non-specialist 
settings.
2,46-49
 Such training needs to be supplemented by contextualised and evidence based 
guidelines to ensure sustained delivery of high quality care. However, our review found an almost 
complete absence of empirical evidence about management of psychiatric emergencies in non-
specialist settings in LMIC. Furthermore, the few guidelines to manage psychiatric emergencies in 
LMIC had notable flaws in the methodology used for their development. The synthesis of 
recommendations from the guidelines and the RCT (Table 1) shows that, while there are treatment 
guidelines for some of the phenotypes (e.g. suicidality, alcohol withdrawal), many phenotypes are not 
represented at all (e.g. stupor, catatonia, mutism). The overall quality of the guidelines was weak and 
there was considerable variation in the recommendations for specific phenotypes, for example in 
terms of medications and dosages. 
 
One of the APA criteria that we used to examine the guidelines was whether they considered patients' 
‘willingness and ability to participate in recommended interventions’. None of the guidelines included 
in our review fully met that criterion. This is a substantial shortcoming for guidelines that are to be 
used to treat psychiatric emergencies, as many of the patients might have reduced capacity to give 
informed consent for treatment. Hence, consideration of the legal provisions and protection provided 
in a specific country to patients with reduced capacity to consent is essential while drafting treatment 
guidelines. This is particularly important, in light of the observation made by the United Nations 
Committee on the Rights of Persons with Disabilities that laws authorising the involuntary treatment 
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on the basis of mental disability are non-compliant with the Convention on the Rights of Persons with 
Disabilities (CRPD).
50
  
 
Our review shows that there is a lack of empirically based and contextually appropriate guidelines on 
how to manage psychiatric emergencies in non-specialist settings in LMIC. In the short term mental 
health systems could follow the recommendations synthesised in the guidelines reviewed in our paper, 
but ultimately should adapt these through rigorous guideline development processes. In addition, 
high-quality evidence from robust designs, ranging from clinical cohorts to randomised controlled 
trials of the management of psychiatric emergencies in specialist mental health settings in LMICs are 
essential to evaluate recommendations and novel approaches.  
 
Guidelines for the management of psychiatric emergencies in non-specialist healthcare settings also 
need recommendations on the management of patients who have reduced capacity to consent which 
are compliant with both local laws and international conventions.  One of the concerns about 
conducting trials in psychiatric emergencies is around ethical issues, in particular in relation to the 
involvement of patients with limited capacity.  However, the TREC trials, which compared two 
drug treatments for people with aggression or agitation due to mental illness in LMIC, have 
demonstrated that rigorous yet pragmatic RCTs can be carried out in people presenting with 
psychiatric emergencies in middle-income country settings and provide a suitable model for future 
trials in non-specialist settings. 
51
  
 
The guidelines should be based primarily on a framework of contextually relevant phenotypic 
presentations with the goal of providing quick relief from distressing psychiatric phenomena. The 
guidelines should be graded according to their feasibility (for example, the cost of medications and 
competencies needed to deliver interventions) and acceptability (for example, the regulatory 
restrictions on their use in specific settings). While there are expected to be some contextual 
specificities, these are likely to be smaller than the universal principles of management of psychiatric 
emergencies and an mhGAP-IG styled set of guidelines may be an appropriate format for synthesis of 
these recommendations.  
 
(Box 1 here)  
 
Our review has several strengths. To the best of our knowledge, this is the first attempt to synthesize 
evidence on the types and management of psychiatric emergencies in non-specialist settings in LMIC. 
We have synthesised data from two sources, thereby increasing the generalizability of our findings. 
Although we have presented the synthesised recommendations we would like to specify that this is by 
no means an endorsement of the quality of the source guidelines and the synthesised 
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recommendations are only as good as the guidelines from which they are derived. Finally, we 
approached the problem using a phenotypic approach, on the grounds that this would be of more 
practical value to frontline health professionals, as compared to the conventional syndromal diagnosis 
approach adopted by mhGAP-IG. One limitation of our review is that our literature search was limited 
to the English language, although our guidelines search covered multiple languages.  In addition, the 
summary treatment recommendations that we have presented are based on the synthesis of guidelines 
which are themselves limited by the weak quality of the evidence base and methodology of their 
development.   
(Box 2 here) 
In conclusion, there is a dearth of high quality guidelines and contextualised primary evidence for 
management of psychiatric emergencies in LMIC. Existing guidelines are restricted to a small number 
of emergency presentations, of uneven quality, and neglect to provide guidance regarding the 
management of people with reduced capacity to consent. Our review thus raises several pertinent 
questions which have major research and clinical implications. There is ample well-documented 
evidence on the assessment and management of psychiatric emergencies in non-specialist settings.
52 
However, this evidence primarily comes from HIC which differ contextually from LMIC on various 
dimensions e.g. availability of trained human resources and medications. Given that much of the 
visible morbidity (and possibly mortality) associated with mental disorders is due to such 
presentations, our findings call for an urgent investment in the expansion of the evidence base for 
management of psychiatric emergencies in LMIC and the development of contextualised guidelines 
following a rigorous methodology. 
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Table 1: Summary of guidelines for the management of ‘neuroses’ spectrum emergencies in non-specialist 
settings in low and middle income countries 
Phenotype Recommendations Source 
guideline/RCT 
from which 
recommendation 
is derived 
Acute anxiety Common recommendations*:  
Clonazepam 0.25- 0.5 sublingually. 
Other recommendations*: 
Diazepam 5-10 mg IV 
Brazil39 
Peru44 
Conversion Common recommendations: None 
Other recommendations: 
Explanation. This must be clear and coherent. It must emphasize the genuineness of the 
condition that it is common, potentially reversible and does not mean that the sufferer is a 
psychotic.  
Treatment of comorbid depression or anxiety if present.  
Diazepam 5-10mg PO/IM/IV. 
Psychosocial intervention 
Refer to higher level for appropriate management. 
Kenya32 
Afghanistan36 
Brazil41 
* Common recommendations: Recommendations made in two or more guidelines; other recommendations: 
Recommendations made in only one guideline. 
Cautionary note: The guidelines from which the information in this table has been derived are only as good as the evidence that has 
informed them and the guideline development process followed. Hence, this information should be used at the clinician's discretion and in 
the context of standard drug formulary recommendations about the various drug dosages. 
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Table 2: Summary of guidelines for the management of externalising spectrum emergencies in non-
specialist settings in low and middle income countries 
Phenotype Recommendations Source 
guideline/RCT 
from which 
recommendation 
is derived 
Agitation, overactive, 
aggressive, violent, 
excitement 
Common recommendations: 
Verbal de-escalation. Assess in pairs in calm settings, with or without family/friends. Keep 
lines of communication open by talking to the patient in a firm but friendly manner until the 
situation is under control. 
Diazepam 2-20 mg IV, 5-10 mg PO or 10 mg IM for acute agitation secondary to anxiety. 
Chlorpromazine 50−150 mg IM or 200 mg QID PO or 200 mg every two hours if very 
aggressive 
Haloperidol 5-10 mg IM 
Physical restraint, if used, should be temporary and in combination with sedation and close 
medical supervision. Restrain patient when necessary without causing injuries. Protect 
yourself, have enough people to handle patient, don’t immediately remove physical 
restraints. 
Other recommendations: 
Risperidone 2mg and Clonazepam 2-4mg. 
Olanzapine 5 mg and Diazepam 10-20mg. 
Quetiapine 100-200mg.   
Haloperidol 5 mg IM + Chlorpromazine 25 mg IM to be repeated once after 1-2 hours if 
necessary. 
Patients >60 years: Haloperidol, 5−10 mg IV or 10−20 mg IM or Chlorpromazine 50−75 
mg IM  
If no response with oral medications then use Lorazepam 2 – 4 mg IM with/without 
Haloperidol 5mg IM or Olanzapine 5 – 10mg IM or Clothiapine (max 360mg/24 hrs). If no 
response then use Diazepam 10 mg IV or zuclopenthixol acetate IM 50 – 150mg (only if 
detained under Mental Health Act). 
 
Refer to general hospital if hemo-dynamically unstable or organic etiology is suspected. 
South Africa26 
Malawi29 
Ghana31 
Ethiopia34 
Vanuatu35 
Afghanistan36 
Peru42,43 
 
 
Cautionary note: The guidelines from which the information in this table has been derived are only as good as the evidence that has 
informed them and the guideline development process followed. Hence, this information should be used at the clinician's discretion and in 
the context of standard drug formulary recommendations about the various drug dosages. 
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Table 3: Summary of guidelines for the management of suicidal behaviour in non-specialist settings in 
low and middle income countries 
Phenotype Recommendations Source 
guideline/RCT 
from which 
recommendation 
is derived 
Suicidal Common recommendations 
Detailed assessment and risk assessment. Talk with the patient and try to understand what is 
the actual problem and try to identify cause for suicidal behaviour  
Treat an underlying mental illness such as a severe depression  
Liaise with relevant parties. Talk to important relatives or friends. 
If there is risk of harming again, ask relatives to spend time with him and ensure that she/he 
is not left alone. Do not leave them alone. Carefully observe patient to minimize risk of 
self-harm. 
Refer to relevant professionals 
Consider the need to hospitalise and hospitalise unless properly supervised at home 
Other recommendations 
Brief Intervention and Contact (BIC): Individual information session (information about 
suicidal behaviour as a sign of psychological and/or social distress, risk and protective 
factors, basic epidemiology, repetition, alternatives to suicidal behaviours, and referral 
options) before discharge followed by nine follow-up contacts (phone calls or visits).  
Form a contract with the patient 
Provide emergency contacts 
Provide adequate psychological care 
Refer or call a pastor 
mhGAP19 
SUPRE-MISS 
RCT22, 23 
Uganda25 
South Africa26 
Malawi29 
Kenya32 
Vanuatu35 
Afghanistan36 
 
Cautionary note: The guidelines from which the information in this table has been derived are only as good as the evidence that has 
informed them and the guideline development process followed. Hence, this information should be used at the clinician's discretion and in 
the context of standard drug formulary recommendations about the various drug dosages. 
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Table 4: Summary of guidelines for the management of and substance use related emergency 
presentations in non-specialist settings in low and middle income countries 
Phenotype Recommendations Source 
guideline/RCT 
from which 
recommendation 
is derived 
Opiate intoxication Common recommendations: None 
Other recommendations: Naloxone 0.4 mg IV. If no response within 2 minutes, repeat 0.4-
0.8 mg twice more at 5-minute interval. 
If antidote for opiate overdose is not available treatment is symptomatic- analgesia and 
sedation 
mhGAP19  
Thai Burmese 
border24 
India27 
Opiate Withdrawal Common recommendations:  
Diazepam 10 mg orally of 10mg intravenously as a starting dose, repeat every hour until 
sedation. 
Clonidine 0.15 mg orally as starting dose daily for 10 days. 
Other recommendations: 
Behaviour tending towards assault: Haloperidol 5-10 mg PO TDS or Chlorpromazine 50-
100 mg PO TDS. 
Pain: Paracetamol 1 gm PO every three hours as necessary. 
Referral to substance treatment centre 
Treat with reducing doses of opioids (methadone, buprenorphine) or alpha-adrenergic 
agents (lofexidine) using either supervised dosing or daily dispensing. 
Treat specific symptoms as needed (diarrhoea, vomiting, muscle pain, insomnia). 
Consider starting opioid agonist maintenance treatment. 
Oral or i.v. rehydration, if necessary. 
mhGAP19 
Thai Burmese 
border24 
Kenya32 
Afghanistan36 
 
 
Amphetamine 
intoxication 
Common recommendations:  
Give diazepam in titrated doses until the person is calm and lightly sedated. 
If psychotic symptoms do not respond to benzodiazepines, then consider using short-term 
antipsychotics. 
Monitor blood pressure, pulse rate, respiratory rate, and temperature every 2 – 4 hours. 
Other recommendations: 
Chlorpromazine 25-50mg IM rapidly reverses the acute agitation. 
Ammonium chloride 500mg PO every 4 hours. 
mhGAP19 
Thai Burmese 
border24 
Colombia37 
Crack intoxication Common recommendations:  
Diazepam fractionated doses until tranquilization and mild sedation.  
Psychotic symptoms: Short-acting antipsychotics.  
Monitor vital signs every 2 hours.  
Other recommendations: 
Watch out for suicidal thoughts.                                                                       
Refer to hospital if chest pain, arrhythmia, violent or aggressive behaviour.     
Colombia37 
Brazil38 
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Crack withdrawal Maintain hydration. 
Avoid physical restraint. 
 Anxiety or restlessness: Diazepam 5-40 mg. 
Motor agitation or psychotic symptoms: Haloperidol IM or Midazolam IM.            
Brazil38 
Cannabis intoxication Maintain hydration  
Tranquilization with Midazolam 5mg IM  
Colombia37 
Alcohol intoxication Common recommendations 
Gastric lavage if alcohol consumed within past two hours 
Position the patient in a lateral position because of possible vomiting and aspiration of 
vomit.  
Monitor clinical state and level of consciousness. Check urine output and vital signs every 
hour initially. 
Look for and treat hypoglycaemia. 50% Dextrose 20 ml IV bolus then 5% IV infusion. 
Rehydrate with iv saline when unconscious, then by mouth when able to swallow safely 
Supportive interventions 
Refer to next level hospital if no improvement. 
Other recommendations 
If signs of encephalopathy, give Thiamine 100mg IV/IM 
If agitated or violent: Diazepam 10 mg IV, repeat if needed after 30 minutes. 
mhGAP19 
Thai Burmese 
border24 
South Africa26 
Namibia28 
Malawi29 
 
Alcohol withdrawal Common recommendations 
 
May need admission to hospital. Monitor clinical status including glucose levels, and 
intervene as indicated 
Thiamine 50-500 mg. PO daily or Thiamine 100-400 mg daily, IM (3-5 days) then PO 
Multi vitamin tablets, Vit B Co tablets daily, Vitamin B12, Folic Acid  
 
Rehydrate orally and intravenously (Sodium Chloride 0.9% in 5% Glucose) as required.  
For psychotic symptom use haloperidol 0·5–5 mg three times a day orally or 
intramuscularly, or 5−10 mg intravenously once a day, or 2–10 mg intramuscularly; or use  
chlorpromazine 25–50 mg intramuscularly 1–3 times a day, or 100–300 mg orally four 
times a day  
Withdrawal seizures: Phenytoin IV 10-15 mg/kg, diazepam IV 
Prophylaxis for withdrawal seizures: Diazepam or Carbamazepine 600-800 mg/day for 48 
hours then taper by 200 mg/day.  
 
Diazepam (PO or IV): Various regimens 
 
Aggressive/Restless: Lorazepam 2-4mg 8hourly IM. Diazepam 10-15 mg IV or 10 mg IM 
or Lorazepam 2-4 mg PO. 
50 ml of 50% dextrose for hypoglycaemia. 
 Other recommendations 
Aggressiveness: Haloperidol 5 mg IV every 20-30 minutes until patient is calm then 5mg 
IV 4-8 hours depending on condition or Hydroxyzine 50-100 mg PO stat, then every 4-6 
hours. 
High blood pressure: Clonidine. 
mhGAP19 
Thai Burmese 
border24 
South Africa26 
Namibia28 
Malawi29 
Kiribati30 
Ghana31 
Kenya32 
Colombia37 
Brazil39,40 
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Manage head trauma and treat pneumonia. 
Phenytoin, oral, 100 mg 3 times daily for 5 days may be used if seizures persist and are not 
controlled by Diazepam alone. 
Seclusion and restraints as necessary. 
Cautionary note: The guidelines from which the information in this table has been derived are only as good as the evidence that has 
informed them and the guideline development process followed. Hence, this information should be used at the clinician's discretion and in 
the context of standard drug formulary recommendations about the various drug dosages. 
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Box 2 Research in context 
Review  
We conducted a systematic review of interventions for psychiatric emergencies and a 
search of LMIC specific treatment guidelines for psychiatric emergencies. Findings 
were then synthesised qualitatively to achieve study objectives. 
Interpretation 
There is a dearth of high quality guidelines and contextualised primary evidence for 
management of psychiatric emergencies in LMIC. There is an urgent need for the 
expansion of the evidence base and the development of contextualised guidelines 
following a rigorous methodology. 
Box 1 Recommendations for the management of psychiatric emergencies in non-
specialist settings in LMIC 
-Guidelines to be developed immediately based on the best available global evidence. 
-Guideline development should follow a rigorous process like those recommended by 
the Grading of Recommendations Assessment, Development and Evaluation (short 
GRADE) Working Group.   
-Treatment recommendations should be for phenotypic presentations. 
-Guidelines should have clear recommendations on management of patients without 
capacity to consent. 
-LMICs should generate high quality primary evidence which will address gaps in the 
evidence and enable the continuing evaluation and refinement of contextualised 
guidelines.   
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WEB EXTRA MATERIAL 
Web Table 1: Quality of RCT included in the review 
CITATION 
(AUTHOR, 
YEAR) 
RANDOM 
SEQUENCE 
GENERATION 
ALLOCATION 
CONCEALMENT 
BLINDING OF 
PARTICIPANTS 
& PERSONNEL 
BLINDING OF 
OUTCOME 
ASSESSMENT 
INCOMPLETE 
OUTCOME 
DATA 
SELECTIVE 
REPORTING 
OTHER 
BIAS 
Fleishmann 
et al. 
200822; 
Bertolete et 
al. 201023 
Low risk. Unclear risk.  
 
Papers mention 
that the allocation 
sequence was 
kept in a separate 
location but do 
not give 
information about 
the safeguards to 
concealment. 
Unclear risk.  
 
Participants were 
blinded but no 
information 
provided about 
blinding of 
investigators 
Unclear risk. 
 
Papers don’t 
provide any 
information. 
High risk. 
 
 Selective 
attrition from 
the 
intervention 
and 
comparison 
arms.  
Not apparent Not 
apparent 
23 
 
Web Table 2: Quality of guidelines 
Domain Criteria Clearly fulfilled 
TREATMENT 
EFFICACY 
Take into consideration the level of 
methodological rigor and clinical 
sophistication of the research supporting 
the intervention. 
mhGAP,
19
 India,
27
 Ghana,
31
 Brazil
38
 
Consider clinical opinion, observation, and 
consensus among recognized experts 
representing the range of views in the field 
mhGAP,
19
 Ghana,
31
 Zambia,
33
 Colombia,
37
 
Brazil
38-41
  
Systematized clinical observation is 
weighted more heavily than un-
systematized observation in evaluating 
treatment efficacy. 
Colombia,
37
 Brazil
38
, Peru
42-44
 
The evaluation of treatment efficacy places 
greatest emphasis on evidence derived 
from sophisticated empirical 
methodologies 
mhGAP,
19
 India,
27
 Ghana
31
  
Recommendations take into consideration 
the treatment conditions to which the 
intervention has been compared 
mhGAP,
19
 India
27
  
Consider whether the treatment gets better 
results than doing nothing. 
mhGAP,
19
 India
27
 
Consider whether the intervention offers 
the patient any benefit beyond simply 
being in treatment. 
mhGAP,
19
 India
27
  
Consider whether an intervention's results 
are better than the results of other 
interventions 
mhGAP,
19
 India
27
  
Consider available evidence regarding 
patient-treatment matching. 
South Africa,
26
 Namibia
28
 
Specify the outcomes the intervention is 
intended to produce 
mhGAP,
19 
India,
27
 Ghana
31
  
CLINICAL 
UTILITY 
Reflect the breadth of patient variables that 
may influence the clinical utility of the 
intervention 
mhGAP,
19 
India,
27
 Malawi,
29
 Ghana,
31
 
Zambia,
33
 Ethiopia,
34
 Brazil
40
 
Take into account the complexity and 
idiosyncrasy of patients' clinical 
presentations 
mhGAP,
19
 South Africa,
26
 India,
27
 
Malawi,
29
 Zambia,
33
  
 
Afghanistan,
36
 
Brazil,
38-41
  
Take into consideration culturally relevant mhGAP,
19 
India,
27
 Vanuatu,
35
 
24 
 
research and expertise Afghanistan
36
 
Take into consideration research 
addressing the issue of the patient's gender  
mhGAP,
19 
Afghanistan
36
  
Take into account research concerning the 
age and developmental level of the patient 
mhGAP,
19
 South Africa,
26
 India,
27
 
Malawi,
29
 Ghana,
31
 Zambia,
33
 Ethiopia,
34
 
Colombia,
37
 Peru,
42-44
  
Take into account research and clinical 
consensus on other relevant patient 
characteristics 
mhGAP,
19
 ndia,
27
 Malawi
29
  
Take into account data on how differences 
between individual health care 
professionals may affect the efficacy of the 
treatment. 
None 
Take into account the effect of the health 
care professional's training, skill, and 
experience on treatment outcome 
Kenya,
32 
Afghanistan
36
  
Take into account the effects on treatment 
outcome of interactions between the 
patient's and the health care professional's 
characteristics 
Afghanistan
36
 
Take into account information pertaining to 
the setting in which the treatment is 
offered. 
Thai-Burmese border,
24
 Uganda,
25
 India,
27
 
Namibia,
28
 Kenya, 
32
 Vanuatu
35
, 
Afghanistan,
36
 Brazil
39
 
Take into account data on treatment 
robustness. 
mhGAP,
19 
India,
27
 Ghana,
31
  
Take into account the intervention's level 
of acceptability to the patients  
India,
27
 Malawi,
29
 Vanuatu, 
35
 
Provide for informed patient choice among 
comparable interventions. 
mhGAP,
19 
India,
27
 Vanuatu
35
  
Consider patients' willingness and ability to 
participate in recommended interventions. 
Brazil
38
 
Explicitly note and evaluate possible 
adverse effects of interventions  
mhGAP,
19 
Thai Burmese border,
24
 
Uganda,
25
 India,
27
 Namibia,
28
 Malawi,
29
 
Ghana,
31
 Zambia,
33
 Ethiopia,
34
 Brazil
38,39
 
Address the preparation of the health care 
professionals to deliver the intervention. 
mhGAP,
19  
Uganda
25
  
Costs should be reported separately from None 
25 
 
consideration of effectiveness. 
Should consider the direct, indirect, short-
term, and long-term costs to the patient, to 
the professional, and to the health care 
system 
None 
GUIDELINE 
DEVELOPMENT 
Composed of individuals with a broad 
range of documented expertise. 
mhGAP,
19 
Ghana,
31
 Zambia,
33
 Colombia,
37
 
Brazil
38,40,41
 
Include one or more individuals with 
expertise in the delivery of services  
mhGAP,
19 
Thai Burmese border,
24
 
Uganda,
25
 South Africa,
26
 India,
27
 
Namibia,
28
 Kiribati,
30
 Ghana,
31
 Kenya,
32
 
Zambia,
33
 Ethiopia,
34
 Vanuatu,
35
 
Afghanistan,
36
Colombia,
37
 Brazil
38-41
, 
Peru
42-44
 
Include one or more individuals with 
expertise in the scientific methodology of 
intervention evaluation  
mhGAP,
19
 South Africa,
26
 Ghana,
31
 
Afghanistan,
36
 Colombia,
37
 Brazil
38-41
 
Include representatives of the patient 
community  
mhGAP,
19
 
Include experts from a broad range of 
relevant disciplines  
mhGAP,
19 
Namibia,
28
 Zambia,
33 
Brazil
41
 
Include members with expertise and 
sensitivity to relevant issues of diversity 
mhGAP,
19
 
Panel members should disclose potential, 
actual, and apparent conflicts of interest. 
mhGAP,
19 
Ghana,
31
  
Panels should maintain the climate of 
openness and free exchange of views  
Brazil
41
 
Selection criteria for guideline 
panellists/qualifications/potential conflicts 
of interest should be described  
Brazil
41
 
Panel procedures and deliberations be 
made available for review by concerned 
parties. 
None 
Before being adopted, the guidelines be 
widely distributed to concerned parties and 
resulting comments be considered  
mhGAP,
19 
Uganda,
25
 Kenya
32
 
Reference list of reviewed in developing 
the guidelines be included with the 
guidelines  
mhGAP,
19
 India,
27
 Brazil
38-41
 
26 
 
Any disagreements between panel 
members be noted in the guidelines. 
Brazil
41
 
Guideline panels agree on specific goals 
for constructing the guidelines. 
mhGAP,
19
 Uganda,
25
 India,
27
 Namibia,
28
 
Malawi,
29
 Ghana,
31
 Kenya,
32
 Vanuatu,
35
 
Afghanistan,
36
 Colombia,
37
 Brazil
40-41
, 
Peru
42-44 
 
Guideline panels identify the audience for 
whom the guideline is intended.  
mhGAP,
19
 Uganda,
25
 South Africa,
26
 
India,
27
 Namibia,
28
 Malawi,
29
 Kenya,
32
 
Ethiopia,
34
 Brazil
39-41
 
Goals of guideline development should be 
clearly identified in the guidelines.  
Uganda,
25
 Kenya,
32
 Brazil
39,41
 
Guideline panel define the process and 
methods of guideline development  
mhGAP,
19
 Brazil
41
 
Guideline panel specify the target condition 
for the treatments under consideration. 
mhGAP,
19
 Thai-Burmese border,
24
 
Uganda,
25
 South Africa,
26
 India,
27
  
Namibia,
28
 Malawi,
29
 Ghana,
31
   Kenya,
32
 
Zambia,
33
 Ethiopia,
34
 Vanuatu,
35 
Afghanistan,
36
 Colombia,
37
 Brazil
38-41
, 
Peru
42-44
  
Guideline panel specify the patient 
population(s) for whom the treatments 
under consideration are intended. 
mhGAP,
19
 Thai-Burmese border,
24
 
Uganda,
25
 South Africa,
26
 India,
27
 
Namibia,
28
 Malawi,
29
 Ghana,
31
 Kenya,
32
 
Zambia,
33
 Ethiopia,
34
 Vanuatu,
35
 
Afghanistan,
36
  Brazil
38-40
, Peru
42-44
  
Guideline panel specify what clinical 
interventions will and will not be 
considered. 
mhGAP,
19
 Brazil
38
 
Guideline panel specify the type of 
professional and the practice setting to 
which the guideline will be applicable. 
mhGAP,
19 
South Africa,
26
 Namibia,
28
 
Ghana,
31
 Kenya,
32
  Ethiopia,
34
 Vanuatu,
35
 
Afghanistan,
36
, Brazil
39
 
Guideline panel decide on specific 
subsidiary goals around which literature 
reviews will be organized. 
mhGAP,
19 
Brazil
41
 
 
Guideline panels should specify the 
methods used for reviewing evidence.  
mhGAP,
19
 Brazil
41
 
27 
 
Guideline panels specify methods for 
evaluating the guidelines they produce. 
mhGAP,
19
 Uganda,
25
 Brazil
41
 
Guideline panels make detailed 
recommendations to facilitate independent 
evaluation of the reliability of the 
guidelines  
Brazil
41
 
Guideline panels make detailed 
recommendations to facilitate independent 
evaluation of the validity of the guidelines  
None 
Guideline panels make detailed 
recommendations to facilitate independent 
evaluation of the clinical utility of the 
guidelines  
Uganda
25
 
Guidelines be reviewed and revised 
periodically  
mhGAP,
19
 Uganda,
25
 Malawi,
29
 Kenya,
32
 
Zambia,
33
 Ethiopia,
34
 Brazil
41
 
 
Appendix 1 
QUESTIONNAIRE ON THE DIAGNOSIS AND MANAGEMENT OF PSYCHIATRIC 
EMERGENCIES IN LOW RESOURCE SETTINGS 
1. Listed below are the common psychiatric phenotypic presentations seen in emergency settings. 
Kindly rate () each one on the scale for relevance in your country/regional setting. 
Phenotype Extremely relevant Moderately relevant Not relevant 
Extreme 
sadness 
Aggression/
Violence 
Agitation 
Mute/uncom
municative 
Self harm 
without 
suicidal 
intent 
Suicidal 
Confusion 
Bizarre 
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behaviour 
Dissociative 
amnesia or 
fugue 
Catatonia 
Substance 
intoxication 
Substance 
withdrawal 
Sudden 
medically 
unexplained 
loss of 
function 
Medically 
unexplained 
seizures 
Stupor 
Trance/posse
ssion 
 
2. Please record any other common phenotypic presentations (apart from the ones above) that 
are relevant in your country/regional settings. 
 
 
3. Please recommend any relevant diagnostic/treatment guidelines for psychiatric emergencies 
from your country/region which we can cite and use for our review. Please send us these 
guidelines as an attachment or indicate from where we can obtain them.  
Please email the completed questionnaire and soft copies of diagnostic/treatment guidelines to 
abhijit.nadkarni@lshtm.ac.uk  
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Appendix 2 
Inclusion and exclusion criteria 
 
   Included Excluded 
Publication type  Any date 
 English language (manuscript to 
specify how many had to be 
excluded because of language) 
 
Study design  Individual RCTs 
 Cluster RCTs 
 Individual non-randomised trials / 
evaluative studies 
 Individual observational studies 
including case series 
Pilot studies 
 
Case reports 
Countries All Low and Middle Income Countries 
(LMIC) as per world bank list of economies 
2013 
High Income Countries (HIC) 
Settings  General hospital 
 Accident & Emergency 
 Primary care 
 NGOs 
 
Specialist psychiatric settings 
Population  Adult patients (18 years and above) 
with a target psychiatric disorder or 
phenotypic presentation (defined 
below) 
 All genders 
Children and adolescents 
Psychiatric 
phenotypic 
presentations 
 Aggressive/agitated behaviour 
 Uncommunicative behaviour 
 Acute distress 
 Sudden loss of bodily function 
(functional) 
 Self-harm/suicidal behaviour 
 Bizarre behaviour 
 Epilepsy/organic seizures 
 Acute adverse effects of 
psychotropic medications 
e.g. dystonia, lithium 
toxicity 
 Delirium 
Psychiatric 
disorder 
 Conversion disorder 
 Panic disorder 
 Panic attack 
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 Anxiety 
 Schizophrenia 
 Psychosis 
 Psychoses 
 Psychotic 
 Mania 
 Manic 
 Hypomania 
 Hypomanic 
 Bipolar affective disorder 
 BPAD 
 Manic depressive 
psychoses 
 Brief psychotic episode 
 Acute and transient 
psychotic disorder 
 Acute stress reaction 
 Adjustment disorder 
 Intoxication  
 Withdrawal 
Intervention Any intervention designed specifically to 
treat the presenting problem (e.g. 
pharmacological agent, psychological 
therapy). 
 
Control group (If 
applicable) 
Any comparison group including: 
 Placebo (for drug trials) and 
treatment as usual (for 
psychotherapy trials). 
 Trials which compare the 
effectiveness of two active 
interventions for example comparing 
drug vs. drug  
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Appendix 3 Medline search strategy 
1. Schizophrenia/ 
2. Psychosis/ 
3. Psychoses/ 
4. Mania/ 
5. Hypomania/ 
6. Bipolar affective disorder/ 
7. BPAD/ 
8. Manic depressive psychosis/ 
9. Manic depressive psychoses/ 
10. Brief psychotic episode/ 
11. Acute and transient psychotic disorder/ 
12. Acute stress reaction/ 
13. Adjustment disorder/ 
14. Or 1-13 
15. Schizophreni$.tw 
16. Psycho$.tw 
17. Mani$.tw 
18. Hypomani$.tw 
19. Bipolar affective disorder.tw 
20. BPAD.tw 
21. Manic depressive psychos$.tw 
22. Brief psychotic episode.tw 
23. Acute and transient psychotic disorder.tw 
24. Acute stress reaction.tw 
25. Adjustment disorder.tw 
26. Or 15-25 
27. Aggress$.tw 
28. Violen$.tw 
29. Agitat$.tw 
30. Mut$.tw 
31. Uncommunicative.tw 
32. Distress$.tw 
33. Self harm$.tw 
34. Self-harm$.tw 
35. Overdose.tw 
36. Suicid$.tw 
37. Parasuicide.tw 
38. Confus$.tw 
39. Bizarre.tw 
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40. Amnesi$.tw 
41. Fugue.tw 
42. Catatoni$.tw 
43. Dissociati$.tw 
44. Intoxicat$.tw 
45. Withdrawal.tw 
46. Conversion .tw 
47. Stupor$.tw 
48. Trance.tw 
49. Possession.tw 
50. Hysteri$.tw 
51. Panic.tw 
52. Anxiety.tw 
53. Or 27-52 
54. 14 or 26 or 53 
55. Acute 
56. Emergency 
57. Crisis 
58. Or 55-57 
59. Treatment/ 
60. Intervention/ 
61. Management/ 
62. Therapy/ 
63. Diagnosis/ 
64. Or 59-63 
65. Treat$.tw 
66. Intervention.tw 
67. Management.tw 
68. Therapy.tw 
69. Diagnosis.tw 
70. Or 65-69 
71. 64 or 70 
72. Developing.tw  
73. Less$ developed.tw 
74. Under developed.tw  
75. Underdeveloped.tw 
76. middle income.tw 
77. low income.tw 
78. lower income.tw 
79. low and middle income.tw 
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80. lmic.tw 
81. lmics.tw 
82. lamics.tw 
83. lamic.tw  
84. third world.tw 
85. lami countr$.tw 
86.  Transitional countr$.tw 
87. Or 72-86 
88. Afghanistan  
89. Armenia$  
90. Bangladesh 
91. Benin 
92. Bhutan 
93. Bolivia 
94. Burkina Faso  
95. Burkina Fasso  
96. Upper Volta  
97. Burundi  
98. Urundi  
99. Cambodia  
100. Khmer Republic  
101. Kampuchea  
102. Cameroon$  
103. Cameron$  
104. Cape Verde  
105. Central African Republic  
106. Chad 
107. Comoros  
108. Comoro Islands  
109. Comores  
110. Congo  
111. Zaire  
112. Cote d Ivoire  
113. Ivory Coast  
114. Djibouti 
115. French Somaliland  
116. East Timor  
117. East Timur  
118. Timor Leste  
119. Egypt  
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120. El Salvador 
121. Eritrea 
122. Ethiopia 
123. Gambia 
124. Gaza  
125. Georgia$ Republic 
126. Ghana 
127. Guatemala  
128. Guinea  
129. Guinea-Bisau 
130. Guiana 
131. Guyana 
132. Haiti 
133. Honduras  
134. India 
135. Indonesia 
136. Kenya 
137. Kiribati 
138. Korea 
139. Kosovo 
140. Kyrgyz$ 
141. Kirghiz$ 
142. Kirgizstan  
143. Lao PDR 
144. Laos 
145. Lesotho 
146. Basutoland 
147. Liberia 
148. Madagasca$  
149. Malagasy  
150. Malawi 
151. Nyasaland 
152. Mali 
153. Mauritania 
154. Micronesia 
155. Moldov$ 
156. Mongolia 
157. Morocco 
158. Ifni  
159. Mozambique 
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160. Myanma$ 
161. Burma 
162. Nepal 
163. Antilles 
164. Nicaragua 
165. Niger$  
166. Pakistan 
167. Papua New Guinea 
168. Palestine 
169. Paraguay 
170. Philippines 
171. Philipines 
172. Phillipines 
173. Phillippines  
174. Rwanda 
175. Ruanda 
176. Samoa$  
177. Navigator Islands  
178. Sao Tome 
179. Senegal  
180. Sierra Leone  
181. Sri Lanka 
182. Ceylon 
183. Solomon Islands 
184. Somali$ 
185. Sudan  
186. Swaziland 
187. Syria$ 
188. Tajikistan 
189. Tadzhikistan 
190. Tadjikistan 
191. Tadzhik 
192. Tanzania 
193. Togo$ 
194. Uganda 
195. Ukraine 
196. Uzbek$ 
197. Vanuatu 
198. New Hebrides 
199. Vietnam 
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200. Viet Nam  
201. West Bank  
202. Yemen 
203. Zambia 
204. Zimbabwe 
205. Rhodesia 
206. Angola 
207. Fiji  
208. Palau 
209. Albania  
210. Gabon  
211. Panama 
212. Algeria  
213. Grenada  
214. Peru   
215. American Samoa  
216. Hungary  
217. Romania 
218. Argentina  
219. Iran 
220. Serbia 
221. Azerbaijan 
222. Iraq 
223. Seychelles 
224. Belarus  
225. Jamaica  
226. South Africa 
227. Belize  
228. Jordan  
229. St. Lucia 
230. Bosnia and Herzegovina  
231. Kazakhstan  
232. St. Vincent and the Grenadines 
233. Botswana  
234. Lebanon  
235. Suriname 
236. Brazil  
237. Libya  
238. Thailand 
239. Bulgaria 
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240. Macedonia, 
241. Tonga 
242. China  
243. Malaysia  
244. Tunisia 
245. Colombia 
246. Maldives 
247. Turkey 
248. Costa Rica 
249. Marshall Islands  
250. Turkmenistan 
251. Cuba  
252. Mauritius  
253. Tuvalu 
254. Dominica  
255. Mexico  
256. Venezuela 
257. Dominican Republic   
258. Montenegro   
259. Ecuador  
260. Namibia 
261. Or 88-260 
262. 87 or 261 
263. 54 AND 58 AND 71 AND 262 
